The third quarter of this year brought numerous high-dollar False Claims Act (FCA) settlements involving a variety of industries and alleged conduct. Below are noteworthy resolutions that reflect recent enforcement trends....more
We are pleased to bring you our 12th annual Healthcare Fraud & Abuse Review. Our Review provides comprehensive coverage of the most significant civil and criminal enforcement issues facing healthcare providers. Each year, we...more
2/27/2024
/ Anti-Kickback Statute ,
CARES Act ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud and Abuse ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Kickbacks ,
Medical Devices ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Qui Tam ,
Settlement ,
Stark Law ,
Telemedicine
Below are noteworthy False Claims Act (FCA) decisions from the third quarter of 2023.
The main issues in the cases are:
Materiality. The Fourth Circuit held that a pharmacist’s efforts to falsify patient eligibility...more
10/19/2023
/ Anti-Kickback Statute ,
Causation ,
Class Action ,
Damages ,
False Claims Act (FCA) ,
Fraud and Abuse ,
Fraudulent Procurement ,
Healthcare ,
Investigations ,
Jury Verdicts ,
Kickbacks ,
Materiality ,
Medicaid ,
Relators ,
Statute of Limitations